| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652214 Treating disorders by application of insulin-like growth factors and analogs |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652144 YC1 gene |
| 07/29/1997 | US5652139 DNA comprising lamb secretion signal sequence and mature IGF-1 sequence |
| 07/29/1997 | US5652133 Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor |
| 07/29/1997 | US5652132 Oxido reductase enzyme system obtainable from P. chrysogenum, the set of genes encoding the same and the use of oxido reductase enzyme systems or genes encoding the same for increasing antibiotic production |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652122 Nucleic acids encoding and methods of making tat-derived transport polypeptides |
| 07/29/1997 | US5652120 Gene coding human epidermal growth factor and process for preparing the same |
| 07/29/1997 | US5652119 Recombinant feline herpesvirus vaccine |
| 07/29/1997 | US5652118 Nucleic acid encoding a novel morphogenic protein, OP-3 |
| 07/29/1997 | US5652117 Human transcription factor IIA |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652111 System for detecting compounds that are potassium channel modulators |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652102 Assay for enterohemorrhagic Escherichia coli 0157:H7 by the polymerase chain reaction |
| 07/29/1997 | US5652101 Specific nucleic acid fragments of the gene for human villin-their use for diagnostic purposes |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5652092 Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide |
| 07/29/1997 | US5651993 Irradiating leukocyte mixture in psoralen presence; reacting with peptide antigens |
| 07/29/1997 | US5651969 Enhancing neurite outgrowth and improving nerve regeneration |
| 07/29/1997 | US5651965 Transformed microbe or plant cell, gene expression |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | US5651963 Heterodimers forms of CSF-1 and pharmaceutical compositions thereof |
| 07/29/1997 | CA1339189C Amblyommin, a new active substance for anticoagulant therapy |
| 07/29/1997 | CA1339188C Removal of protein a from antibody preparations |
| 07/29/1997 | CA1339187C Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 07/29/1997 | CA1339186C Process for reducing the aggregate content of growth hormone-like materials |
| 07/29/1997 | CA1339185C Lymphocyte inhibition by hla peptides |
| 07/29/1997 | CA1339111C Antiviral agent |
| 07/29/1997 | CA1339106C Hirullin polypeptides having anticoagulant activity |
| 07/29/1997 | CA1339105C Modified proteins |
| 07/29/1997 | CA1339104C Hirudin derivative |
| 07/29/1997 | CA1339102C Dna molecules useful in plant protection |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/29/1997 | CA1339071C Thrombus control agent |
| 07/29/1997 | CA1339069C Polypeptide-induced monoclonal receptors to protein ligand |
| 07/29/1997 | CA1339068C High molecular weight cell-associated protein of campylobacter pylori |
| 07/29/1997 | CA1339067C Antigenic compositions and methods for their production and use |
| 07/24/1997 | WO1997026538A1 Allele-specific peptide epitope strategy for vaccine development |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026372A1 Diagnostic test to determine the malignancy of smooth muscle tumors |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026360A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/24/1997 | WO1997026359A1 System for the expression of heterologous antigens as fusion proteins |
| 07/24/1997 | WO1997026358A1 Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins |
| 07/24/1997 | WO1997026357A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | WO1997026339A1 Method of protecting crop plants against insect pests |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026334A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026333A1 Humanized green fluorescent protein genes and methods |
| 07/24/1997 | WO1997026332A1 Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |
| 07/24/1997 | WO1997026325A1 Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
| 07/24/1997 | WO1997026322A2 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | WO1997026321A2 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026320A2 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | WO1997026280A1 Isolation of fibrinogen by affinity chromatography |
| 07/24/1997 | WO1997026279A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026278A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026277A2 Morphogen analogs and methods for producing them |
| 07/24/1997 | WO1997026276A2 Vertebrate fringe proteins |
| 07/24/1997 | WO1997026275A1 Protein occlusion for delivery of small molecules |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026273A1 Borrelia burgdorferi outer membrane proteins |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026271A1 Novel tumor suppressor gene, dpc4 |
| 07/24/1997 | WO1997026013A1 Obesity protein formulations |
| 07/24/1997 | WO1997026009A1 Compounds capable of inhibiting hiv-1 infection |
| 07/24/1997 | WO1997026007A1 Mycobacterium antigens and methods for their detection |
| 07/24/1997 | WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | WO1997026004A1 Obesity protein formulations |
| 07/24/1997 | WO1997026001A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025861A1 H2-m modified transgenic animals |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997021993A3 Nuclear receptor ligands and ligand binding domains |
| 07/24/1997 | WO1997018308A3 K-atp channel protein and methods relating to it |
| 07/24/1997 | WO1997015668A3 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | WO1997010258A3 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | WO1997006176A3 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/24/1997 | DE19602295A1 Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe Conjugate to distinguish between diseased and healthy tissue |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2246431A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2246268A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2244228A1 Morphogen analogs and methods for producing them |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |